Patents by Inventor Marsela Braunstein

Marsela Braunstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting the histone pathway to detect and overcome anthracyclin resistance
    Patent number: 11015226
    Abstract: There is provided herein a method for determining a likelihood of resistance to anthracyclin, or poor survival, in a patient with cancer by identifying upregulation of at least one histone gene in the patient.
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: May 25, 2021
    Assignee: ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
    Inventors: Melanie Spears, John M. Bartlett, Marsela Braunstein, Paul M. Krzyzanowski, Irina Kalatskaya, Lincoln Stein
  • Targeting the Histone Pathway to Detect and Overcome Anthracyclin Resistance
    Publication number: 20180282819
    Abstract: There is provided herein a method for determining a likelihood of resistance to anthracyclin, or poor survival, in a patient with cancer by identifying upregulation of at least one histone gene in the patient.
    Type: Application
    Filed: October 4, 2016
    Publication date: October 4, 2018
    Inventors: Melanie Spears, John M. Bartlett, Marsela Braunstein, Paul M. Krzyzanowski, Irina Kalatskaya, Lincoln Stein